Avid Bioservices Inc (CDMO)

[freethemice]

Here is my estimate for the enrollment of the first-line NSCLC trial.
My latest guesstimate is that in the control arm 75% of the patients had died by July 2012. I assume that the
control arm MOS = 12 months. I also assume that the treatment arm has yet to reach the point where
75% have died, now 5 months after the control arm did so. I expect Peregrine to wait until that happens
before reporting the "final" MOS. I am still hoping for mid-February.